Shenzhen Lifotronic Technology Co Asset Resilience Ratio

Latest as of December 2024: 2.53%

Shenzhen Lifotronic Technology Co asset resilience ratio. Shenzhen Lifotronic Technology Co (688389) has an Asset Resilience Ratio of 2.53% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Shenzhen Lifotronic Technology Co (688389) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥73.25 Million
≈ $10.72 Million USD Cash + Short-term Investments

Total Assets

CN¥2.89 Billion
≈ $423.56 Million USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio of Shenzhen Lifotronic Technology Co (2024–2024)

Asset resilience ratio of Shenzhen Lifotronic Technology Co from 2024 to 2024. This chart shows how Shenzhen Lifotronic Technology Co's Asset Resilience Ratio has changed over time. Read debt load of Shenzhen Lifotronic Technology Co for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Shenzhen Lifotronic Technology Co's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Shenzhen Lifotronic Technology Co total assets.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥73.25 Million 2.53%
Total Liquid Assets CN¥73.25 Million 2.53%

Asset Resilience Insights

  • Limited Liquidity: Shenzhen Lifotronic Technology Co maintains only 2.53% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Shenzhen Lifotronic Technology Co Industry Peers by Asset Resilience Ratio

Compare Shenzhen Lifotronic Technology Co's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Demant A/S
CO:DEMANT
Medical Devices -2.59%
Shanghai Sanyou Medical Co Ltd
SHG:688085
Medical Devices 7.69%
CareRay Digital Medical Technology Co Ltd
SHG:688607
Medical Devices 16.21%
Cleo Diagnostics Ltd
AU:COV
Medical Devices 94.64%
Memphasys Ltd
AU:MEM
Medical Devices 0.00%
Cochlear Ltd
AU:COH
Medical Devices 9.76%
Anteris Technologies Global Corp
AU:AVR
Medical Devices 33.27%
Polynovo Ltd
AU:PNV
Medical Devices 0.04%

Shenzhen Lifotronic Technology Co Asset Resilience Ratio by Year (2024–2024)

Shenzhen Lifotronic Technology Co asset resilience ratio by year from 2024 to 2024. The table below shows the annual Asset Resilience Ratio data for Shenzhen Lifotronic Technology Co.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 2.53% CN¥73.25 Million
≈ $10.72 Million
CN¥2.89 Billion
≈ $423.56 Million
--
pp = percentage points

About Shenzhen Lifotronic Technology Co

SHG:688389 China Medical Devices
Market Cap
$731.09 Million
CN¥5.00 Billion CNY
Market Cap Rank
#9979 Global
#2598 in China
Share Price
CN¥11.66
Change (1 day)
-2.26%
52-Week Range
CN¥9.59 - CN¥14.38
All Time High
CN¥37.22
About

Shenzhen Lifotronic Technology Co., Ltd. researches, develops, manufactures, and markets medical devices for diagnostics, therapy, clinical medicine, skin, and human health related purposes in China. It offers a comprehensive range of in vitro diagnostic equipment and reagents, including electrochemiluminescence immunoassay analyzers, glycated hemoglobin analyzers, specific protein analyzers, blo… Read more